2C-B

2,5-Dimethoxy-4-bromophenethylamine

NexusBeesVenusBromoTusiPink CocaineSpectrum
Open Interactive Guide →

2C-B is a synthetic phenethylamine psychedelic with both hallucinogenic and empathogenic properties. Known for visual intensity and euphoria with a clear headspace. Dose-sensitive: small variations dramatically alter the experience. Unpredictable potency and frequent adulteration make it high-risk. Increasingly prevalent in club and chemsex scenes.

How It Works

Partial agonist at serotonin 5-HT2A and 5-HT2C receptors, mediating psychedelic and hallucinogenic effects. May also interact with dopamine receptors (D2, D3) contributing to empathogenic properties. Acts as a releasing agent for serotonin and dopamine.

Legal Status

Controlled in most countries. Classified as a Schedule I substance in the US and similarly restricted internationally. Illegal for all non-research purposes.

Dosage Guide (Oral)

LevelAmount (milligrams (mg))
Threshold5-10 mg
Light10-15 mg
Common15-25 mg
Strong25-35 mg
Heavy35+ mg

Note: Dose-sensitive: 5mg difference between light and intense experiences. Poorly dosed or adulterated substances are extremely common. No reliable street doses exist. Insufflation typically requires 30-50% less material but causes severe nasal irritation. Purity and potency vary dramatically between batches.

Organ System Impacts

cardiovascular — Moderate
Increases heart rate, blood pressure, and cardiac workload. Risk of arrhythmias, palpitations, and in rare cases myocardial infarction, especially in susceptible individuals or at high doses.
neurological — Moderate
Potent serotonergic activity produces hallucinations, dissociation, and altered cognition. Hallucinogenic effects can trigger latent psychotic disorders. Seizure risk in susceptible individuals at high doses.
ocular — Low
Pupil dilation (mydriasis), visual distortions, and enhanced color perception. Possible photophobia. No permanent ocular damage reported, but impaired vision during acute effects.
dermatological — Low
Profuse sweating common, especially in club/dance settings. Hyperthermia risk in hot environments. Possible rash from adulterated substances.
respiratory — Low
No direct respiratory toxicity. Mild tachypnea possible from sympathomimetic effects. Hyperthermia may increase respiratory rate.
hepatic — Low
Minimal hepatic toxicity reported. Metabolism primarily via monoamine oxidase and other liver enzymes. No significant liver damage in acute or chronic use documented.
hematological — Low
No direct hematological effects. Possible dehydration in prolonged use in hot environments affecting blood volume and viscosity.
renal — Low
Sympathomimetic effects may cause hypertension affecting renal perfusion. Dehydration and SIADH-like effects possible. Risk of rhabdomyolysis and acute kidney injury if hyperthermia occurs.
gastrointestinal — Low
Nausea and vomiting common, particularly with oral route and higher doses. Possible stomach cramping and diarrhea. Appetite suppression during acute effects.
musculoskeletal — Low
Jaw clenching and teeth grinding (bruxism) common. Muscle tension and rigidity possible at higher doses. Risk of rhabdomyolysis with hyperthermia in dance/exertion settings.

Effects

Desired Effects

Negative Effects

Rare but Serious

Drug Interactions

MAOI antidepressants (phenelzine, tranylcypromine) and certain antidepressants — dangerous

Severe serotonin syndrome risk. Combined serotonergic activity may cause fatal hypertensive crisis, hyperthermia, seizures, and cardiovascular collapse.

Stimulants (cocaine, amphetamines, methamphetamine, MDMA) — dangerous

Compounded sympathomimetic effects causing severe tachycardia, hypertension, arrhythmias, and hyperthermia. High overdose and sudden cardiac death risk, especially in exertion/club settings.

SSRI antidepressants (sertraline, fluoxetine, paroxetine) — moderate

Increased serotonin syndrome risk, though less severe than with MAOIs. Symptoms include agitation, confusion, rapid heart rate, and hyperthermia. Risk increases with higher 2C-B doses.

Other serotonergic drugs (tramadol, certain opioids, dextromethorphan) — moderate

Additive serotonergic effects increasing serotonin syndrome risk. Tramadol is particularly dangerous. Symptoms include agitation, confusion, muscle rigidity, and hyperthermia.

Cannabis — moderate

Potentiation of psychedelic effects and dissociation. Increased anxiety and paranoia risk. Cannabis may increase tachycardia and cardiovascular stress.

Alcohol — moderate

Impairs judgment and increases risky behavior. Alcohol dehydrates, increasing hyperthermia risk in dance settings. May worsen nausea and increase cardiovascular stress.

Benzodiazepines — low

May reduce anxiety during peak. However, combination may impair judgment and coordination. Benzodiazepines can blunt psychedelic effects if high dose of benzo is used.

Detection Times

2C-B is not detected on standard drug panels. Specialized mass spectrometry testing is required.

Urine

Requires GC-MS or LC-MS/MS. May cross-react on amphetamine assays. Detection window: up to 3 days.

Blood

Short blood detection window. Detection window: up to 1 days.

Hair

Hair testing is theoretically possible but rarely done. Detection window: up to 90 days.

Harm Reduction Tips

Withdrawal Symptoms

Severity: Low

Not applicable — 2C-B does not produce dependence.

Psychological

Emergency Information

Call 911 If:

Warning Signs

What To Do

  1. Immediately move to a cool, well-ventilated area and lie down with feet elevated.
  2. Cool the body with cold compresses, ice packs, or immersion in cool (not ice) water if hyperthermia.
  3. Monitor vital signs and consciousness level.
  4. Sip water slowly if conscious and no vomiting.
  5. If seizure occurs, protect from injury and position on side.
  6. Keep person calm and reassured; provide supportive care.
  7. If symptoms persist or worsen, contact emergency services.
Harm reduction information only. This is not medical advice. If you are experiencing a medical emergency, call 911 immediately.